Ionis Pharmaceuticals

Youtube Subscribe

Open: 39.2 Close: 40.74 Change: 1.54

You're running out of time to find out about Ionis Pharmaceuticals using an AI.

How much time have you spent trying to decide whether investing in Ionis Pharmaceuticals? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Ionis Pharmaceuticals are: …

Concept Map

Semantic Network

Stock Summary

SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin am.

Today's Summary

Commonwealth Equity Services LLCs holdings in Ionis Pharmaceuticals were worth $781,000 at the end of the most recent reporting period. The position reports to the Executive Director, Security & Compliance Officer.

Today's News

Ionis Pharmaceuticals Inc (IONS) Stock Price Today, News, Quotes, FAQs and Fundamentals StockTwits Logo Join the Conversation! Build your trading network Follow your favorite assets Link Your Portfolio and become verified Sign Up Log In. Log In Free Trial. Commonwealth Equity Services LLCs holdings in Ionis Pharmaceuticals were worth $781,000 at the end of the most recent reporting period. Ionis Pharmaceuticals Inc. (IONS) has a unique PE ratio of -18.30. The position reports to the Executive Director, Security & Compliance Officer. Network Systems Senior Manager in companies like IONIS PHARMACEUTICALS INC range from $170,600 to $207,300 with the average base salary of $185,630. Ionis Pharmaceuticals Inc. is headquartered in Carlsbad, California, with offices in Boston, Massachusetts, and Dublin, Ireland. The employee data is based on information from people who have self-report their past or current employments at Ionis. None of the information on this page has been provided or approved by Ionis.

Stock Profile

"Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops Cimdelirsen to inhibit the production of growth hormone receptor; IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. Ionis Pharmaceuticals, Inc. was incorporated in 1989 and is based in Carlsbad, California."

Keywords

The game is changing. There is a new strategy to evaluate Ionis Pharmaceuticals fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Ionis Pharmaceuticals are: Ionis, Pharmaceuticals, Inc, IONS, Log, base, information, and the most common words in the summary are: pharmaceutical, therapeutic, ionis, pharma, stock, inc, bioscience, . One of the sentences in the summary was: The position reports to the Executive Director, Security & Compliance Officer.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pharmaceutical #therapeutic #ionis #pharma #stock #inc #bioscience.

Read more →

Youtube Subscribe

---